Physician profile
Paige E Cummings
NPI 1417701202
$1,611.35
in general payments reported to CMS, 2019-2025
8 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what 79% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $191 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,611.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $400.63 | 2024-2025 | |
| Access Pro Medical, LLC | $326.82 | 2025 | Matriderm |
| Axogen | $226.66 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Polynovo North America LLC | $205.32 | 2025 | Novosorb Btm |
| Motiva USA, LLC | $172.94 | 2025 | |
| Mentor Worldwide LLC | $136.82 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $123.66 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $18.50 | 2025 | Trumatch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.